These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9661036)

  • 1. In vivo antibacterial activities of sanfetrinem cilexetil, a new oral tricyclic antibiotic.
    Tamura S; Miyazaki S; Tateda K; Ohno A; Ishii Y; Matsumoto T; Furuya N; Yamaguchi K
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1858-61. PubMed ID: 9661036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro and in vivo activities of cefpodoxime proxetil against penicillin-resistant Streptococcus pneumoniae].
    Kawada H; Kitayama A; Fukuoka T; Ishii C; Abe T; Kakuta M; Domon H; Ohya S; Utsui Y
    Jpn J Antibiot; 1999 Aug; 52(8):533-40. PubMed ID: 10587878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro activity of sanfetrinem against isolates of Streptococcus pneumoniae and Staphylococcus aureus.
    Johnson AP; Warner M; Speller DC
    J Antimicrob Chemother; 1998 Nov; 42(5):643-6. PubMed ID: 9848449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo antibacterial activities of L-084, a novel oral carbapenem, against causative organisms of respiratory tract infections.
    Miyazaki S; Hosoyama T; Furuya N; Ishii Y; Matsumoto T; Ohno A; Tateda K; Yamaguchi K
    Antimicrob Agents Chemother; 2001 Jan; 45(1):203-7. PubMed ID: 11120966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of CS-834 against experimental pneumonia caused by penicillin-susceptible and -resistant Streptococcus pneumoniae in mice.
    Fukuoka T; Kawada H; Kitayama A; Koga T; Kubota M; Harasaki T; Kamai Y; Ohya S; Yasuda H; Iwata M; Kuwahara S
    Antimicrob Agents Chemother; 1998 Jan; 42(1):23-7. PubMed ID: 9449255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo antibacterial activities of GV129606, a new broad-spectrum trinem.
    Di Modugno E; Broggio R; Erbetti I; Lowther J
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2742-8. PubMed ID: 9420050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo antibacterial activities of OPC-20011, a novel parenteral broad-spectrum 2-oxaisocephem antibiotic.
    Matsumoto M; Tamaoka H; Ishikawa H; Kikuchi M
    Antimicrob Agents Chemother; 1998 Nov; 42(11):2943-9. PubMed ID: 9797230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of sanfetrinem (GV104326), a new trinem antimicrobial agent, versus Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
    Doern GV; Pierce G; Brueggemann AB
    Diagn Microbiol Infect Dis; 1996 Sep; 26(1):39-42. PubMed ID: 8950528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem.
    Fukuoka T; Ohya S; Utsui Y; Domon H; Takenouchi T; Koga T; Masuda N; Kawada H; Kakuta M; Kubota M; Ishii C; Ishii C; Sakagawa E; Harasaki T; Hirasawa A; Abe T; Yasuda H; Iwata M; Kuwahara S
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2652-63. PubMed ID: 9420035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model.
    Tateda K; Takashima K; Miyazaki H; Matsumoto T; Hatori T; Yamaguchi K
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1520-5. PubMed ID: 8726030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo antibacterial activities of CS-834, a new oral carbapenem.
    Yamaguchi K; Domon H; Miyazaki S; Tateda K; Ohno A; Ishii K; Matsumoto T; Furuya N
    Antimicrob Agents Chemother; 1998 Mar; 42(3):555-63. PubMed ID: 9517932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic/Pharmacodynamic Evaluation of a Novel Aminomethylcycline Antibiotic, KBP-7072, in the Neutropenic Murine Pneumonia Model against Staphylococcus aureus and Streptococcus pneumoniae.
    Lepak AJ; Zhao M; Liu Q; Wang P; Wang Y; Bader JC; Ambrose PG; Andes DR
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30559140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo antibacterial activities of clarithromycin.
    Ono T; Numata K; Nagate T; Mitsuhashi S; Inoue M
    Chemotherapy; 1996; 42(3):159-69. PubMed ID: 8983882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro bactericidal activities of new oral penem, faropenem against the various clinical isolates].
    Matsuzaki K; Nishiyama T; Hasegawa M; Kobayashi I; Kaneko A; Sasaki J
    Jpn J Antibiot; 1999 May; 52(5):431-8. PubMed ID: 10480050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postantibiotic effect of sanfetrinem compared with those of six other agents against 12 penicillin-susceptible and -resistant pneumococci.
    Spangler SK; Lin G; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2173-6. PubMed ID: 9333043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Entry of sanfetrinem into human polymorphonuclear granulocytes and its cell-associated activity against intracellular, penicillin-resistant Streptococcus pneumoniae.
    Cuffini AM; Tullio V; Bonino A; Allocco A; Palarchio AI; Carlone NA
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1745-50. PubMed ID: 9661015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sanfetrinem and sanfetrinem-cilexetil: disposition in rat and dog.
    Iavarone L; Bottacini M; Pugnaghi F; Morandini C; Grossi P
    Xenobiotica; 1997 Jul; 27(7):693-709. PubMed ID: 9253146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrolones Are a Novel Class of Macrolide Antibiotics Active against Key Resistant Respiratory Pathogens In Vitro and In Vivo.
    Čipčić Paljetak H; Verbanac D; Padovan J; Dominis-Kramarić M; Kelnerić Ž; Perić M; Banjanac M; Ergović G; Simon N; Broskey J; Holmes DJ; Eraković Haber V
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5337-48. PubMed ID: 27353268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MIC and time-kill studies of antipneumococcal activity of GV 118819X (sanfetrinem) compared with those of other agents.
    Spangler SK; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1997 Jan; 41(1):148-55. PubMed ID: 8980771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
    Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
    Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.